Model
Edge
Cidara Therapeutics Inc.
CDTX
Filing Type
10-Q
Filing Date
8/6/2025
Updated
8/7/25, 2:15 PM
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q2
EX-31.1
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-31.2
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-32.1
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-32.2
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002